The MDS Foundation Celebrates MDS World Awareness Day With Their 4th Annual Move for MDS 5k Walk at Boston Common and Virtually Around the World
20 oct. 2021 10h05 HE | MDS Foundation, Inc.
YARDVILLE, N.J., Oct. 20, 2021 (GLOBE NEWSWIRE) -- The MDS Foundation, a global non-profit advocacy organization is proud to announce its fourth annual Move for MDS walk at Boston Common on Sunday,...
ambulero_4a.png
Ambulero’s Gene Therapy Candidate AMB-301 Granted US Orphan Drug Designation For Treatment of Severe Vascular Disease
19 oct. 2021 09h18 HE | Ambulero
MIAMI, Oct. 19, 2021 (GLOBE NEWSWIRE) -- Ambulero Inc., a biotechnology company (“Ambulero” or the “Company”) developing new cell and gene therapy treatments for patients suffering from severe...
Saniona completes submission of manufacturing data for Tesomet capsules to U.S. FDA
18 oct. 2021 08h00 HE | Saniona AB
PRESS RELEASE 18 October 2021 Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on rare diseases, today announced that it has completed the submission of all information...
Saniona slutför inlämningen till FDA av tillverkningsdata för Tesometkapslar
18 oct. 2021 08h00 HE | Saniona AB
PRESSMEDDELANDE 18 oktober 2021 Saniona (OMX: SANION), ett biofarmaceutiskt företag med klinisk utveckling fokuserad på sällsynta sjukdomar, meddelar idag att alla uppgifter som det amerikanska...
Saniona to participate in multiple upcoming virtual investor conferences
06 oct. 2021 08h00 HE | Saniona AB
PRESS RELEASE 6 October 2021 Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on rare diseases, today announced that it will present at multiple upcoming virtual investor...
Saniona medverkar vid flera kommande digitala investerarkonferenser
06 oct. 2021 08h00 HE | Saniona AB
PRESSMEDDELANDE 6 oktober 2021 Saniona (OMX: SANION), ett biofarmaceutiskt företag med klinisk utveckling fokuserad på sällsynta sjukdomar, meddelar idag att bolaget kommer att hålla presentationer...
logo_ProQR-150x150.png
ProQR Appoints Theresa Heggie as Chief Commercial Officer
04 oct. 2021 08h00 HE | ProQR Therapeutics N.V.
Senior leader with extensive global rare disease commercialization experienceTop-line data from Phase 2/3 pivotal Illuminate trial of sepofarsen for CEP290-mediated LCA10 on track for H1 2022 ...
VectivBio_Logo_RGB_Color.png
VectivBio Announces Closing of Comet Therapeutics Acquisition
21 sept. 2021 07h15 HE | VectivBio AG
BASEL, Switzerland, Sept. 21, 2021 (GLOBE NEWSWIRE) -- VectivBio Holding AG (“VectivBio”) (Nasdaq: VECT), a clinical-stage biopharmaceutical company pioneering novel transformational treatments for...
Saniona appoints Robert Hoffman to Board of Directors as Chair of the Audit Committee
16 sept. 2021 11h50 HE | Saniona AB
PRESS RELEASE 16 September 2021 Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on rare diseases, today announced the appointment of Robert E. Hoffman to its board of...
Saniona utser Robert Hoffman till ny styrelseledamot och ordförande för revisionsutskottet
16 sept. 2021 11h50 HE | Saniona AB
PRESSMEDDELANDE 16 september 2021 Saniona (OMX: SANION), ett biofarmaceutiskt företag med klinisk utveckling fokuserad på sällsynta sjukdomar, tillkännager idag att styrelsen kompletteras med Robert...